These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10582480)

  • 21. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited.
    Zarek SM; Muasher SJ
    Fertil Steril; 2011 Jun; 95(8):2449-55. PubMed ID: 21550037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists.
    Felberbaum R; Diedrich K
    Hum Reprod; 1999 Sep; 14 Suppl 1():207-21. PubMed ID: 10573035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to ovarian stimulation.
    Diedrich K; Felberbaum R
    Hum Reprod; 1998 Jun; 13 Suppl 3():1-13; discussion 14-7. PubMed ID: 9755411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is there a role for GnRH analogs in ovulation stimulation for in vitro fertilization?].
    Belaisch-Allart J; Mayenga JM
    Contracept Fertil Sex; 1998 Nov; 26(11):761-3. PubMed ID: 9864882
    [No Abstract]   [Full Text] [Related]  

  • 25. Human menopausal gonadotropin versus highly purified-hMG in controlled ovarian hyperstimulation for in-vitro fertilisation: does purity improve outcome?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2010 Oct; 26(10):733-5. PubMed ID: 20500109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between follicular stimulation and luteal stimulation protocols with clomiphene and HMG in women with poor ovarian response.
    Li Y; Yang W; Chen X; Li L; Zhang Q; Yang D
    Gynecol Endocrinol; 2016; 32(1):74-7. PubMed ID: 26370530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian stimulation for IVF in France: choice and results according to protocols and gonadotrophin].
    Rossin B; Pouly JL; Belaisch-Allart J; de Mouzon J;
    Gynecol Obstet Fertil; 2009; 37(11-12):864-72. PubMed ID: 19833539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The luteal phase after ovarian stimulation.
    Kolibianakis EM; Devroey P
    Reprod Biomed Online; 2002; 5 Suppl 1():26-35. PubMed ID: 12537779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro fertilization in women over the age of 40].
    Belaïsch-Allart J; de Mouzon J; Bachelot A; Logerot-Lebrun H; Rufat P
    Contracept Fertil Sex; 1993 May; 21(5):367-70. PubMed ID: 7920918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New advances in the treatment of infertility in women with ovarian failure.
    Morris RS; Sauer MV
    Curr Opin Obstet Gynecol; 1993 Jun; 5(3):368-77. PubMed ID: 8329653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developments in drugs for ovarian stimulation.
    Ludwig M; Westergaard LG; Diedrich K; Andersen CY
    Best Pract Res Clin Obstet Gynaecol; 2003 Apr; 17(2):231-47. PubMed ID: 12758097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols.
    Zorn JR; Barata M; Brami C; Epelboin S; Nathan C; Papageorgiou G; Quantin P; Rolet F; Savale M; Boyer P
    Hum Reprod; 1988 Feb; 3(2):235-9. PubMed ID: 2965712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent data concerning the use of ovulation inductors during in vitro fertilization programs.
    Frydman R
    Acta Eur Fertil; 1985; 16(1):5-11. PubMed ID: 3925678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program].
    Pilka L; Ventruba P; Soska J; Cupr Z; Veselý J; Tesarík J; Trávník P; Dvorák M
    Cesk Gynekol; 1987 Mar; 52(2):105-9. PubMed ID: 3107845
    [No Abstract]   [Full Text] [Related]  

  • 35. The science behind 25 years of ovarian stimulation for in vitro fertilization.
    Macklon NS; Stouffer RL; Giudice LC; Fauser BC
    Endocr Rev; 2006 Apr; 27(2):170-207. PubMed ID: 16434510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin-releasing hormone antagonists: impact of IVF practice and potential non-assisted reproductive technology applications.
    Tarlatzis BC; Bili HN
    Curr Opin Obstet Gynecol; 2003 Jun; 15(3):259-64. PubMed ID: 12858116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IVF endocrinology: the Edwards era.
    Hillier SG
    Mol Hum Reprod; 2013 Dec; 19(12):799-808. PubMed ID: 24113591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian stimulation protocols for IVF: is more better than less?
    Alper MM; Fauser BC
    Reprod Biomed Online; 2017 Apr; 34(4):345-353. PubMed ID: 28169189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian Stimulation in Poor Responders: Have We Made Progress?
    Roman R; Mussarat N; Detti L
    Curr Pharm Biotechnol; 2017 Nov; 18(8):614-618. PubMed ID: 28969562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovulation induction in the era of recombinant gonadotropins and GnRH analogues.
    Insler V; Lunenfeld B
    Isr J Med Sci; 1996 Feb; 32(2):79-89. PubMed ID: 8631655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.